Research in our laboratory focuses on neurodevelopmental disorders with an emphasis on the pathological processes underlying specific disorders as well as rational therapeutic strategies based on such understanding.

We currently have active programmes on both Rett Syndrome (MECP2 mutations) and CDKL5 disorder.

 

neuropharmacology